ALMR Alamar Biosciences, Inc.

38.13USD+10.97%Mkt Cap: 2.65B $P/E: —

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a prote…

Key Statistics

Company
Market Cap2.65B USD
Enterprise Value2.19B USD
Revenue (TTM)100.42M USD
Gross Profit41.70M USD
Net Income (TTM)-29.82M USD
Revenue/Share4.24 USD
Last Price38.13 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees286
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-63.34
PEG—
EV/EBITDA-58.31
EV/Revenue21.77
P/S23.74
P/B7.62
EPS (TTM)-1.20
EPS (Forward)-0.54
52W Range
18.8498% of range38.54
52W High38.54 USD
52W Low18.84 USD
Profitability
Gross Margin56.20%
Oper. Margin-45.98%
EBITDA Margin-37.33%
Profit Margin-40.18%
ROE18.76%
ROA-21.30%
Growth
Revenue Growth82.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-53.61M USD
CapEx (TTM)6.38M USD
FCF Margin—
FCF Yield—
Net Debt-198.65M USD
Net Debt/EBITDA5.30
Balance Sheet
Debt/Equity-0.26
Current Ratio11.85
Quick Ratio9.67
Book Value/Sh4.51 USD
Cash/Share3.60 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)35.40 USD
Upside (mean)-7.2%
Target Range31.00 USD – 45.00 USD
31.00-7.2% to mean45.00
# Analysts5
Ownership
Shares Out.69.39M
Float36.16M
Insiders22.24%
Institutions58.39%
Short Interest
Short Ratio7.0d
Short % Float4.96%
Short % Out.3.06%
Shares Short2.12M
Short (prev mo.)2.08M
Technical
SMA 5030.75 (+24.0%)
SMA 20026.55 (+43.6%)
Beta—
S&P 52W Chg14.58%
Avg Vol (30d)444.24K
Avg Vol (10d)502.30K
Technical Indicators
RSI (14)67.7
MACD1.2310
MACD Signal0.8209
MACD Hist.+0.4101
BB Upper37.55 USD
BB Middle31.91 USD
BB Lower26.27 USD
BB Width35.34%
ATR (14)2.401 USD
Vol Ratio (20d)1.13x